Promising Results on Ebola Antiviral
The US Army Medical Research Institute of Infectious Diseases reports promising preclinical results on an antiviral for Ebola. In findings presented at ID Week 2015 in San Diego, CA, Travis Warren, PhD, a principal investigator said a collaboration with Gilead on a compound known as GS-5734 completely protected rhesus monkeys after they were infected with the virus.
Should Doctors Go Bare? Infection Control Debate Rages
In the UK's National Health Service, physicians are "bare below the elbows" meaning they wear scrubs and not white coats, dress shirts and ties. At ID Week, in an entertaining but serious debate, two infection control specialists tackled the question of whether US physicians should also go bare.
Emerging Diseases: Tapeworm Brain Cysts on Rise in US
Neurologists seeing patients with seizures who are from developing countries in Latin America, sub-Saharan Africa and other countries with much poverty and poor sanitation should be on the lookout for neurocysticercosis, a condition related to exposure to tapeworms.
Q&A with the CDC's Nimalie Stone: A Coordinated Approach to Antibiotic Stewardship in Nursing Homes
As a medical epidemiologist for Long-term Care in the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC), Nimalie Stone ensures seven core elements of stewardship are maintained throughout longterm care: leadership commitment, accountability, drug expertise, action, tracking, reporting, and education.
EV-D68: Will Last Year's Outbreak Be Repeated?
Enterovirus D68 caused hundreds of hospitalizations and five deaths across the US in 2014. It left many mysteries, including why so many people got it since a CDC study showed the US populace is basically immune the virus, one discovered in 1962. Why it was linked to paralysis in some children is also unclear. But three experts at ID Week 2015 today agreed, EV-D68 will be back.
Longer Interval Between HIV Screening Affects CD4+ Counts at the Time of Diagnosis
October 9th 2015Researchers report that waiting more than 2 years between HIV screenings is associated with double the rate of AIDS by CD4+ criteria at the time of HIV diagnosis when compared with more frequent testing.
Drug Resistance: What Happens Inside the Nose?
A University of Colorado School of Medicine hypothesized that the nasal microbiome could be protective against MRSA colonization in some individuals. Reporting at ID Week 2015 in San Diego, CA, Mary Bessenden, MD and colleges looked at 26 persistently MRSA colonized people and 26 non-colonized controls.
Q&A with Helen Boucher from Tufts Medical Center: Infection Prevention Vs. Infection Management
The problem of antibiotic resistance is a national health problem, a national security problem, and a global problem. The hope is that we'll get more of our citizens involved and active in playing a role in addressing this crisis.
Case History: When an HIV Epidemic Hit a 'One-Stoplight Town'
No one was more shocked than local HIV specialists when an epidemic of HIV hit a small town in Indiana. Diane Janowicz, MD, a Bloomington, Indiana AIDS/HIV specialist gave ID Week attendees a detailed description of how she and other health officials and entities handled the case.
Ebola: It Just Keeps on Giving, Says Survivor Ian Crozier, MD
Ian Crozier, MD, an infectious disease expert working treating Ebola patients in West Africa, had to admit himself to his own emergency treatment unit. His riveting account of his recovery included an episode in which virus lurking in one eye turned it from blue to green. Crozier got a standing ovation in his talk today at ID Week 2015 in San Diego, CA.